$343.11
-7.37 (-2.10%)
At Close: Jun 04, 2026
Keysight (KEYS) Solution to Enhance Digital Learning Experience
02:31pm, Friday, 17'th Mar 2023
Keysight (KEYS) unveils a unified digital learning platform to support educators and students with lab tools, measurement analysis tools, and world-class learning resources.
Keysight (KEYS) Solutions Enhance Data Transfer Capabilities
11:25am, Thursday, 09'th Mar 2023
Keysight (KEYS), in collaboration with research institutes, achieved higher baud rates, enabling faster data transmission by allowing higher bandwidth rates with reduced wavelength requirements.
National Instruments picks Fortive, Keysight as challengers to Emerson's bid -sources
06:03am, Friday, 03'rd Mar 2023
Measurement equipment maker National Instruments Corp has decided that Fortive Corp and Keysight Technologies Inc have the potential to top Emerson Electric Co's $7 billion bid for the company, three
Keysight (KEYS) Partners DOCOMO & NTT to Boost 6G Capabilities
02:32pm, Thursday, 02'nd Mar 2023 Zacks Investment Research
Keysight (KEYS), NTT DOCOMO and NTT will pool their technological expertise to enable the industry to tide over the potential technical challenges associated with the introduction of 6G applications.
Keysight (KEYS) Partners DOCOMO & NTT to Boost 6G Capabilities
11:18am, Thursday, 02'nd Mar 2023
Keysight (KEYS), NTT DOCOMO and NTT will pool their technological expertise to enable the industry to tide over the potential technical challenges associated with the introduction of 6G applications.
Wall Street Breakfast: What Moved Markets
05:55am, Saturday, 25'th Feb 2023 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
06:10pm, Wednesday, 22'nd Feb 2023 Benzinga
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formula
Why Shares in Keysight Technologies Crashed Today
05:52pm, Wednesday, 22'nd Feb 2023 The Motley Fool
Disappointing guidance sent the stock sharply lower today.
Keysight (KEYS) Q1 Earnings Beat Estimates, Top Line Grows Y/Y
05:43pm, Wednesday, 22'nd Feb 2023 Zacks Investment Research
Keysight (KEYS) successfully navigated through macroeconomic uncertainty and moderate demand trends and registered a robust top-line expansion owing to its strong operating discipline and diverse port
Keysight (KEYS) Q1 Earnings Beat Estimates, Top Line Grows Y/Y
02:18pm, Wednesday, 22'nd Feb 2023
Keysight (KEYS) successfully navigated through macroeconomic uncertainty and moderate demand trends and registered a robust top-line expansion owing to its strong operating discipline and diverse port
Why Shares in Keysight Technologies Crashed Today
12:52pm, Wednesday, 22'nd Feb 2023
Disappointing guidance sent the stock sharply lower today.
Keysight Technologies stock faces worst day as shares also lag S&P 500
12:11pm, Wednesday, 22'nd Feb 2023
Keysight Technologies Inc. KEYS, -13.71% shares were heading for their worst day on record Wednesday after the electronic design and test solutions company's forecast fell short of Wall Street expecta
Keysight (KEYS) Q1 Earnings and Revenues Beat Estimates
10:35pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
Keysight (KEYS) delivered earnings and revenue surprises of 9.19% and 0.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Keysight Technologies Stock Is Nosediving During Tuesday's After-Hours Session
09:58pm, Tuesday, 21'st Feb 2023 Benzinga
Keysight Technologies Inc (NYSE: KEYS) shares are trading lower by 7% to $170 in Tuesday's after-hours session. The company reported first-quarter financial results and issued worse-than-expected F
Keysight Technologies, Inc. (KEYS) Q1 2023 Earnings Call Transcript
07:55pm, Tuesday, 21'st Feb 2023
Keysight Technologies, Inc. (NYSE:KEYS ) Q1 2023 Results Conference Call February 21, 2023 4:30 PM ET Company Participants Jason Kary - VP, Treasurer and IR Satish Dhanasekaran - President and CEO Nei
Sign In
Buy KEYS